甜梦口服液联合氟哌噻吨美利曲辛治疗 神经症临床研究.docVIP

精品论文 参考文献 甜梦口服液联合氟哌噻吨美利曲辛治疗 神经症临床研究 李隆文 张春红 黄咏歌 古国宁 李必宏 钟凤鸣 陈丽花 广州市萝岗区中医医院 广东 广州 510530 【摘要】目的：研究甜梦口服液联合氟哌噻吨美利曲辛治疗神经症的临床效果。方法：选取我院收治的100 例神经症患者随机分为2 组，对照组50 例患者采 用地西泮联合氟哌噻吨美利曲辛治疗；观察组50 例患者采用甜梦口服液联合氟哌噻吨美利曲辛治疗。采用 汉密尔顿抑郁量表(HAMD)及匹兹堡睡眠指数（PSQI）对治疗效果进行评价。结果：两组患者用药前HAMD、PSQI评分差异无显著性（p＞0.05）。用药8 周 后观察组患者平均HAMD、PSQI评分较治疗前降低，观察组降低幅度明显大于对照组，差异有统计学意义（P＜0.05）。结论：甜梦口服液联合氟哌噻吨美利曲辛 能有效的降低神经症患者的评分，且与地西泮比较，甜梦口服液在改善患者睡眠质量上优势明显。 【关键词】甜梦口服液；氟哌噻吨美利曲辛；神经症 Clinical Observation on Tianmeng Oral Liquid combined with Flupentixol-Melitracen in treating neurosis Li Longwen, Zhang Chunhong, Huang Yongge, Gu Guoning, Li Bihong, Zhong Fengming, Chen Lihua Guangzhou Luogang District Hospital of TCM, Guangzhou 510530, China 【Abstract】 Objective: To investigate clinical effects of Tianmeng Oral Liquid combined with Flupentixol-Melitracen in treating neurosis. Methods: 100 patients with neurosis hospitalized in our hospital were randomly divided into two groups. In the control group, 50 patients were treated with diazepam combined with Flupentixol-Melitracent. 50 patients treated with Tianmeng Oral Liquid combined with Flupentixol-Melitracent were as observation group. Treatment effectiveness was assessed using Hamilton depressive scale (HAMD) and Pittsburgh Sleep Quality Index (PSQI). Results: There was no significant difference in the HAMD and PSQI score in two groups before administration (pgt;0.05). After 8 weeksrsquo; administration, the average HAMD and PSQI score in the observation group was lower than the levels of pre-administration, and the decreasing range was obviously higher than that in the control group. The difference was statically significant (plt;0.05).Conclusions: The score of patients with neurosis could be significantly reduced by using Tianmeng Oral Liquid combined with Flupentixol-Melitracen. Compared with diazepam, the Tianmeng Oral Liquid showed obvious superiority in improving patientsrsquo; sleep quality. 【Key Words】Tian